CompletedPhase 2NCT01135251

Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy

Studying Acquired peripheral neuropathy

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Neurotune AG
Principal Investigator: Ruggero G Fariello, MD FAAN
Neurotune AG
Intervention: dimiracetam(drug)
Enrollment: 116 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2009 – 2010

Study locations (1)

Aurora Hospital Triple Research, Port Elizabeth, South Africa

Collaborators

Cross Research S.A. · Triclinium clinical trial project managment LTD

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01135251 on ClinicalTrials.gov

← Back to all trials